patients taking isradipine (DynaCirc) have a higher risk of angina

October 1996

The several studies about calcium blockers over the last year have raised many questions about safety. These drugs have been linked to a higher risk of MI...GI bleeding...and even cancer.

That's why there's so much interest in a brand-new study in JAMA that suggests patients taking isradipine (DynaCirc) have a higher risk of angina...and other vascular complications.

These unexpected results come from a study that was designed for a DIFFERENT purpose...to see if either isradipine or HCTZ slows the development of atherosclerosis.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote